Net Cash Provided by (Used in) Operating Activities |
-11.6M |
USD |
-170% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
5.43M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
450M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
80.1M |
shares |
+0.11% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-6.14M |
USD |
-202% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
29.5M |
USD |
-1.92% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
6.63M |
USD |
+16.8% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
10.3M |
USD |
-14.1% |
Q4 2023 |
FY 2023 |
Deferred Income Tax Expense (Benefit) |
3.04M |
USD |
+5.81% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
671K |
USD |
+68.6% |
Q4 2023 |
FY 2023 |
Deferred Federal Income Tax Expense (Benefit) |
3.95M |
USD |
+63% |
Q2 2024 |
Q2 2024 |
Current Income Tax Expense (Benefit) |
1.22M |
USD |
+48.5% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
688M |
USD |
+0.39% |
Q2 2024 |
Q2 2024 |
Current State and Local Tax Expense (Benefit) |
524K |
USD |
+28.4% |
Q2 2024 |
Q2 2024 |
Current Federal Tax Expense (Benefit) |
343K |
USD |
+308% |
Q2 2024 |
Q2 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
-908K |
USD |
-300% |
Q2 2024 |
Q2 2024 |
Interest Expense |
37.7M |
USD |
+33.5% |
Q1 2024 |
Q1 2024 |